Observational Study on the Clinical Use of Ex Vivo Lung Perfusion (XPS™) for Lung Transplantation

Recruiting

• Conditions: Lung Transplantation

• Registration Number: NCT06795516
• Lead Sponsor: Hannover Medical School

Brief Summary

Clinical use of ex-vivo perfusion for lung transplantation. Collection, storage and processing of patient data for outcome analysis.

Detailed Description

Not available

Study Timeline

• Status Verified: 2025-01
• Study First Submitted: 2025-01-17
• Study First Submitted QC: 2025-01-27
• Last Update Submitted: 2025-01-27
• Study First Posted: 2025-01-28
• Last Update Posted: 2025-01-28
• Study Start: 2025-02
• Primary Completion: 2027-01
• Study Completion: 2027-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• Min Age 18 years
• Acceptance of the organ using the XPS™ ex vivo lung perfusion system is made by the center based on clinical assessment and visual inspection

Exclusion Criteria

• The usual criteria for the assessment of donors apply
• The transplanting surgeon is not satisfied with the lung assessment on the XPS™ according to clinical criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Survival of patients 1 year after transplantation	1 year after transplantation

Secondary Outcome Measures

Name	Time	Method
Occurrence of primary graft dysfunction (PGD) after transplantation	0, 24, 48, 72 hours postTx

Trial Locations

Locations (1)

Hannover Medical School, Department of Cardiothoracic, Transplant and Vascular Surgery; 🇩🇪 Hannover, Germany